Anti-(human Beta-amyloid Protofibril) (human-mus Musculus Monoclonal BAN2401 Heavy Chain) Uses, Dosage, Side Effects and more
Anti-(human Beta-amyloid Protofibril) (human-mus Musculus Monoclonal BAN2401 Heavy Chain) is an experimental drug that is currently in clinical trials for the treament of Alzheimer's disease.
| Attribute | Details |
|---|---|
| Trade Name | Anti-(human Beta-amyloid Protofibril) (human-mus Musculus Monoclonal BAN2401 Heavy Chain) |
| Generic | Lecanemab |
| Lecanemab Other Names | Immunoglobulin G1, anti-(human beta-amyloid protofibril) (human-mus musculus monoclonal BAN2401 heavy chain), disulfide with human-mus musculus monoclonal BAN2401 light chain, dimer, Lecanemab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
